![Dao Tian Fu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Attualmente, Dao Tian Fu occupa la posizione di presidente di RemeGen Co. In precedenza il dottor Fu è stato Manager-Quality Control & Research presso Neose Pharmaceuticals, Inc., Executive Director & Vice President presso Livzon Pharmaceutical Group, Inc. e General Manager presso Livzon MABPharm Inc. (una filiale della Livzon Pharmaceutical Group, Inc.), vicepresidente della ricerca alla Genzyme Corp. e direttore della divisione Primedica alla rEVO Biologics, Inc. Ha ricevuto un dottorato dalla Iowa State University e una laurea presso l'Università di Shandong.
Precedenti posizioni note di Dao Tian Fu
| Società | Posizione | Fine |
|---|---|---|
| REMEGEN CO., LTD. | Presidente | 12/05/2023 |
| LIVZON PHARMACEUTICAL GROUP INC. | Direttore/Membro del Consiglio | 27/09/2019 |
Livzon MABPharm Inc.
 Livzon MABPharm Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and sells biopharmaceutical products & antibody drug | Amministratore Delegato | 01/09/2019 |
| EPIRUS BIOPHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 25/07/2016 |
| REVO BIOLOGICS INC | Corporate Officer/Principal | 01/01/2001 |
Formazione di Dao Tian Fu
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Livzon Pharmaceutical Group, Inc.
 Livzon Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, chemical preparation medicines and vaccines products | Health Technology |
LungLife AI, Inc.
 LungLife AI, Inc. Medical SpecialtiesHealth Technology Develops early detection solutions for lung cancer | Health Technology |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shandong University
 Shandong University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zalicus, Inc.
 Zalicus, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops pharmaceutical products for patients suffering from pain and immuno-inflammatory diseases | Health Technology |
Neose Pharmaceuticals, Inc. | |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology Develops and commercializes specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions | Health Technology |
EPIRUS Biopharmaceuticals, Inc.
 EPIRUS Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biosimilar monoclonal antibodies | Health Technology |
Livzon MABPharm Inc.
Livzon MABPharm Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and sells biopharmaceutical products & antibody drug | Health Technology |
RemeGen Co., Ltd.
 RemeGen Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures cancer drugs | Health Technology |
